Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy?
- PMID: 29226397
- DOI: 10.1111/apt.14321
Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy?
Comment in
-
Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy? Authors' reply.Aliment Pharmacol Ther. 2018 Jan;47(1):147-148. doi: 10.1111/apt.14398. Aliment Pharmacol Ther. 2018. PMID: 29226402 No abstract available.
Comment on
-
Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study.Aliment Pharmacol Ther. 2017 Sep;46(6):589-598. doi: 10.1111/apt.14224. Epub 2017 Jul 28. Aliment Pharmacol Ther. 2017. PMID: 28752637
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
